Study of AI’s ability to diagnose pancreatic cancer: John A. Chabot, MD, Executive Director of The Pancreas Center speaks about this study and where we go now.
As we bid farewell to another transformative year, pride and gratitude swell among us. We encourage everyone to take a moment to reflect on all the remarkable strides made in patient care, from the lab to the operating room, in 2023.
A groundbreaking Phase II clinical trial for a mRNA neoantigen vaccine for pancreatic cancer is underway. With a mortality rate of nearly 90 percent, this could be a transformative development in the treatment of pancreatic cancer. Dr. John Chabot shares what you need to know.
Interview with Vincent Duron, MD about his work, career, and fetal surgery including minimally invasive prenatal repair of spina bifida and treatment of CDH.
